pubmed-article:11425506 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:11425506 | lifeskim:mentions | umls-concept:C0021289 | lld:lifeskim |
pubmed-article:11425506 | lifeskim:mentions | umls-concept:C0034693 | lld:lifeskim |
pubmed-article:11425506 | lifeskim:mentions | umls-concept:C0013030 | lld:lifeskim |
pubmed-article:11425506 | lifeskim:mentions | umls-concept:C0597357 | lld:lifeskim |
pubmed-article:11425506 | lifeskim:mentions | umls-concept:C0205245 | lld:lifeskim |
pubmed-article:11425506 | lifeskim:mentions | umls-concept:C1704632 | lld:lifeskim |
pubmed-article:11425506 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
pubmed-article:11425506 | lifeskim:mentions | umls-concept:C0871261 | lld:lifeskim |
pubmed-article:11425506 | lifeskim:mentions | umls-concept:C0171023 | lld:lifeskim |
pubmed-article:11425506 | lifeskim:mentions | umls-concept:C2911692 | lld:lifeskim |
pubmed-article:11425506 | lifeskim:mentions | umls-concept:C1706817 | lld:lifeskim |
pubmed-article:11425506 | lifeskim:mentions | umls-concept:C1517945 | lld:lifeskim |
pubmed-article:11425506 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:11425506 | pubmed:dateCreated | 2001-6-26 | lld:pubmed |
pubmed-article:11425506 | pubmed:abstractText | Previous work has suggested that the therapeutic efficacy of olanzapine might be partially dependent on action at the D(1)-dopamine (DA) receptor site. Because early DA loss can lead to supersensitive D(1)-DA receptors, effects of olanzapine were investigated in adult rats given lesions to DA-containing neurons as neonates. In these animals, locomotor effects of SKF-38393 (a D(1)-DA agonist) were attenuated by olanzapine, but at doses (5 and 10 mg/kg) that decreased activity when given alone. Olanzapine prevented induction of striatal Fos protein by SKF-38393 and partially attenuated the long-term "priming" effect of repeated SKF-38393 treatment. Olanzapine also antagonized the stimulant effects of quinpirole (a D(2)-type DA agonist) in animals lesioned as young adults, at doses lower than those necessary to antagonize SKF-38393-induced activity. In addition, olanzapine antagonized apomorphine-induced self-injurious behavior in neonate-lesioned rats in a dose-related fashion. Attenuation of self-injury in this animal model suggests that olanzapine should be tested against this symptom in patient populations. | lld:pubmed |
pubmed-article:11425506 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11425506 | pubmed:language | eng | lld:pubmed |
pubmed-article:11425506 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11425506 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:11425506 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11425506 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11425506 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11425506 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11425506 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11425506 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11425506 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11425506 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11425506 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11425506 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11425506 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:11425506 | pubmed:month | Aug | lld:pubmed |
pubmed-article:11425506 | pubmed:issn | 0893-133X | lld:pubmed |
pubmed-article:11425506 | pubmed:author | pubmed-author:BreeseG RGR | lld:pubmed |
pubmed-article:11425506 | pubmed:author | pubmed-author:EyoE EEE | lld:pubmed |
pubmed-article:11425506 | pubmed:author | pubmed-author:KnappD JDJ | lld:pubmed |
pubmed-article:11425506 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:11425506 | pubmed:volume | 25 | lld:pubmed |
pubmed-article:11425506 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:11425506 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:11425506 | pubmed:pagination | 224-33 | lld:pubmed |
pubmed-article:11425506 | pubmed:dateRevised | 2011-5-18 | lld:pubmed |
pubmed-article:11425506 | pubmed:meshHeading | pubmed-meshheading:11425506... | lld:pubmed |
pubmed-article:11425506 | pubmed:meshHeading | pubmed-meshheading:11425506... | lld:pubmed |
pubmed-article:11425506 | pubmed:meshHeading | pubmed-meshheading:11425506... | lld:pubmed |
pubmed-article:11425506 | pubmed:meshHeading | pubmed-meshheading:11425506... | lld:pubmed |
pubmed-article:11425506 | pubmed:meshHeading | pubmed-meshheading:11425506... | lld:pubmed |
pubmed-article:11425506 | pubmed:meshHeading | pubmed-meshheading:11425506... | lld:pubmed |
pubmed-article:11425506 | pubmed:meshHeading | pubmed-meshheading:11425506... | lld:pubmed |
pubmed-article:11425506 | pubmed:meshHeading | pubmed-meshheading:11425506... | lld:pubmed |
pubmed-article:11425506 | pubmed:meshHeading | pubmed-meshheading:11425506... | lld:pubmed |
pubmed-article:11425506 | pubmed:meshHeading | pubmed-meshheading:11425506... | lld:pubmed |
pubmed-article:11425506 | pubmed:meshHeading | pubmed-meshheading:11425506... | lld:pubmed |
pubmed-article:11425506 | pubmed:meshHeading | pubmed-meshheading:11425506... | lld:pubmed |
pubmed-article:11425506 | pubmed:meshHeading | pubmed-meshheading:11425506... | lld:pubmed |
pubmed-article:11425506 | pubmed:meshHeading | pubmed-meshheading:11425506... | lld:pubmed |
pubmed-article:11425506 | pubmed:meshHeading | pubmed-meshheading:11425506... | lld:pubmed |
pubmed-article:11425506 | pubmed:meshHeading | pubmed-meshheading:11425506... | lld:pubmed |
pubmed-article:11425506 | pubmed:meshHeading | pubmed-meshheading:11425506... | lld:pubmed |
pubmed-article:11425506 | pubmed:meshHeading | pubmed-meshheading:11425506... | lld:pubmed |
pubmed-article:11425506 | pubmed:year | 2001 | lld:pubmed |
pubmed-article:11425506 | pubmed:articleTitle | Effect of olanzapine on functional responses from sensitized D1-dopamine receptors in rats with neonatal dopamine loss. | lld:pubmed |
pubmed-article:11425506 | pubmed:affiliation | Department of Psychiatry, Skipper Bowles Center for Alcohol Studies, University of North Carolina School of Medicine, Chapel Hill 27599-7178, USA. sheryl.moy@css.unc.edu | lld:pubmed |
pubmed-article:11425506 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:11425506 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
pubmed-article:11425506 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |